#ChoiceBroking #Morning Tea

1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
While there would be little immediate impact of Britain’s exit from the European Union (EU) on Indian pharmaceutical companies
operating there, it is becoming clear they would have to brace for a new regulatory framework. It would be significantly different
to that of the EU. “From a long term perspective, companies will have to tinker with their strategy. For example, unified EU
regulations that apply uniformly may no longer apply to the United Kingdom (UK) and a new set of compliances may be required.
Sovereignty was one of the pillars of the ‘leave’ campaign.
Technical Outlook : Stock is operating below its 21 day short term to 250 day long term moving average, it indicates its negative
bias across all time frame. It has also breached its prior consolidation phase which is also negative sign. Momentum oscillator RSI
has faced resistance around 53 level and thereafter moving lower with lower high and lower low, also it is sustaining below its
average line. So one can create sell for intraday in the range of 888 to 895 range with SL of 910 and for the target of 860 level.
WOCKPHARMA
TATASTEEL
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
27th June 2016
Sell in the range of 312-315 for the Target of 306 with SL of 317
Sell in the range of 888 to 895 for the Target of 860 with SL of 910
Among all Indian companies, Tata Steel earns the highest, 57.5 per cent of its revenue, from its European operations — due to its
2007 acquisition of Corus Steel. The acquisition did not make any money for the group and to make matters worse, it faced
competition from cheaper Chinese imports. Increased costs in its UK operations due to a costly pension plan expedited the
financial mess. The company is now in the process of selling its British plants and merging its European operations with
ThyssenKrupp in a 50-50 joint venture, a German magazine reported on Friday.
Technical Outlook: Recently Stock has breached its upper consolidation phase, it can be considered as distribution phase at
higher level. Stock has formed a break away gap which signifies downward movement. From long time, momentum oscillator RSI
is sloping downward with lower high and lower low and stock is operating below its average line. So once can create short
position for intraday perspective in the range of 312 to 315 with SL of 317 and for the target of 306.
This week Indian market may have to deal with global uncertainty sparked by Britain’s decision to exit the European Union.
Experts say that India also stands at a risk of losing foreign institutional investors (FII) money at the moment. The 30-share BSE
Sensex plunged 604.51 points or 2.24 percent to 26397.71 and the 50-share NSE Nifty slipped 181.85 points or 2.20 percent to
8088.60 on Friday. The BSE Midcap and Smallcap indices were down 1-1.5 percent. Ridham Desai of Morgan Stanley is of the
opinion that Brexit is a global event but certainly it is nothing similar to the 2008 financial crisis though the threat of the EU
breaking out is a real one. He adds says that Indian markets are in the middle of a run now but he doesn't believe that Nifty will
hit 8300 soon.
Asia markets opened mixed on Monday, as traders continued to digest the UK's unexpected vote to leave the European Union
(EU). Australia's ASX 200 dropped 0.91 percent in early trade; the financial subindex, which accounts for nearly half of the
broader index, was down 2.19 percent, with major Australian banks down more than 1 percent each. Shares of ANZ dropped 3.11
percent, Commonwealth Bank of Australia down 1.85 percent, Westpac off 2.08 percent and NAB off by 2.44 percent. In South
Korea, the Kospi was off 0.7 percent. Bucking the trend was Japan, where the Nikkei 225 saw a 1.61 percent gain in early trade.
The leave camp secured 51.9 percent of the vote in the UK referendum, with 17.4 million votes. The ramifications of the
unexpected result have been reverberating across the wider political and economic establishment since Friday.

2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
27th June 2016
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 24/06/2016 514366 CITIZYN JAGDISHKUMAR LILABHAI BHATIYA S 74000 3.73
2 24/06/2016 538351 AFEL RAJENDRA SINGH RAWAT S 55000 9.52
3 24/06/2016 539200 NOBPOL VARADHARAJA PERUMAL JEYA BASKAR B 47000 4.21
4 24/06/2016 539200 NOBPOL RAJESHWAR MAHTO S 43100 4.21
5 24/06/2016 538351 AFEL BHAGATI RAM S 41000 9.55
6 24/06/2016 538351 AFEL BHAGATI RAM B 41000 9.55
7 24/06/2016 538351 AFEL MANJEET SINGH S 36022 9.55
8 24/06/2016 538351 AFEL SATISH CHANDRAKANT SHINDE S 32014 9.57
9 24/06/2016 538351 AFEL SATISH CHANDRAKANT SHINDE B 27904 9.64
10 24/06/2016 538351 AFEL MANJEET SINGH B 25988 9.57
Corporate Action:
Capital First Limited; Annual General Meeting/ Dividend - Rs 2.40/- Per Share
Pfizer Limited; Dividend - Rs.15/- Per Share
Result Calendar:
BELLGRP, EXCAST & VIJSHAN
Corporate Action / Result Calendar
HDIL, INDIACEM, JETAIRWAYS, JPASSOCIAT & RCOM

3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
27th June 2016
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kapil Shah
Digitally signed by Kapil Shah
DN: cn=Kapil Shah, o=Choice Equity Pvt Ltd,
ou=Research Team,
email=kapil.shah@choiceindia.com, c=US
Date: 2016.06.27 09:00:57 +05'30'